97 related articles for article (PubMed ID: 11366758)
1. Drug watch.
Whitson S
Posit Aware; 1999; 10(3):16-7. PubMed ID: 11366758
[TBL] [Abstract][Full Text] [Related]
2. New nonnucleoside reverse transcriptase inhibitors.
GMHC Treat Issues; 1999 Feb; 13(2):10. PubMed ID: 11366114
[TBL] [Abstract][Full Text] [Related]
3. The latest antiviral news.
Vazquez E
Posit Aware; 1999; 10(2):44. PubMed ID: 11366851
[TBL] [Abstract][Full Text] [Related]
4. Second-generation drugs fight resistant virus.
STEP Perspect; 1999; 99(1):3. PubMed ID: 11367160
[TBL] [Abstract][Full Text] [Related]
5. T-20--a fusion drug, first of several to come.
TreatmentUpdate; 1998 Dec; 10(10):2. PubMed ID: 11366015
[TBL] [Abstract][Full Text] [Related]
6. HIV type 1 integrase inhibitors: from basic research to clinical implications.
Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
[TBL] [Abstract][Full Text] [Related]
7. Is HIV drug resistance a limiting factor in the development of anti-HIV NNRTI and NRTI-based vaginal microbicide strategies?
Martinez J; Coplan P; Wainberg MA
Antiviral Res; 2006 Sep; 71(2-3):343-50. PubMed ID: 16787667
[TBL] [Abstract][Full Text] [Related]
8. New developments in HIV drug resistance.
Cane PA
J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i37-40. PubMed ID: 19675018
[TBL] [Abstract][Full Text] [Related]
9. DPC-083. DuPont Pharmaceuticals.
Lim ML
Curr Opin Investig Drugs; 2001 Sep; 2(9):1209-12. PubMed ID: 11717806
[TBL] [Abstract][Full Text] [Related]
10. Transmitted multidrug resistant HIV-1: new and investigational therapeutic approaches.
Shet A; Markowitz M
Curr Opin Investig Drugs; 2006 Aug; 7(8):709-20. PubMed ID: 16955682
[TBL] [Abstract][Full Text] [Related]
11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
12. New antiretroviral drugs, part II: NRTIs, NNRTIs, and beyond.
Murphy RL
AIDS Clin Care; 1999 Jun; 11(6):47-9, 51, 53-4. PubMed ID: 11366882
[TBL] [Abstract][Full Text] [Related]
13. New antiretroviral agents.
Gallant JE
Hopkins HIV Rep; 1999 Mar; 11(2):3, 12. PubMed ID: 11366248
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 resistance to first- and second-generation non-nucleoside reverse transcriptase inhibitors.
Ghosn J; Chaix ML; Delaugerre C
AIDS Rev; 2009; 11(3):165-73. PubMed ID: 19654858
[TBL] [Abstract][Full Text] [Related]
15. Current concepts in antiretroviral therapy failure.
del Rio C
Top HIV Med; 2006; 14(3):102-6. PubMed ID: 16946454
[TBL] [Abstract][Full Text] [Related]
16. T-20: a new class of drugs.
STEP Perspect; 1999; 99(1):6. PubMed ID: 11367163
[TBL] [Abstract][Full Text] [Related]
17. Current insights into reverse transcriptase inhibitor-associated resistance.
Wainberg MA; White AJ
Antivir Ther; 2001; 6 Suppl 2():11-9. PubMed ID: 11678474
[No Abstract] [Full Text] [Related]
18. New drugs for old.
Winston A; Stebbing J
J HIV Ther; 2005 Mar; 10(1):11-6. PubMed ID: 15951729
[TBL] [Abstract][Full Text] [Related]
19. New anti-HIV agents and targets.
De Clercq E
Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
[TBL] [Abstract][Full Text] [Related]
20. Drug-resistant HIV-1 in the semen of men receiving antiretroviral therapy with acute sexually transmitted infections.
Taylor S; Sadiq ST; Weller I; Kaye S; Workman J; Cane PA; Bennett J; Copas AJ; Drake SM; Pillay D
Antivir Ther; 2003 Oct; 8(5):479-83. PubMed ID: 14640396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
